Andrew M Reynolds1, Kristin Kelly Porter2. 1. Department of Radiology, University of Alabama at Birmingham School of Medicine, 619 19th Street South, JT N325, Birmingham, AL, 35249-6830, USA. 2. Department of Radiology, University of Alabama at Birmingham School of Medicine, 619 19th Street South, JT N325, Birmingham, AL, 35249-6830, USA. kkporter@uabmc.edu.
Abstract
PURPOSE OF REVIEW: The majority of enhancing renal masses cannot be characterized through imaging as malignant or benign; however, such characterization could save patients from unnecessary surgery and/or biopsy and associated morbidity. Herein, we review the recent literature on the emerging use of 99mTc-MIBI SPECT/CT in preoperative differentiation of enhancing renal masses. RECENT FINDINGS: Recent reports have shown that 99mTc-MIBI SPECT/CT imaging can differentiate mitochondrial-rich, benign, or indolent renal masses from renal cell carcinoma. These studies demonstrate good correlation between a positive 99mTc-MIBI SPECT/CT scan and a pathologically proven diagnosis of renal oncocytoma and hybrid oncocytic/chromophobe tumor. In addition, there is excellent correlation between a negative scan and a diagnosis of clear cell subtype of renal cell carcinoma. Preoperative 99mTc-MIBI SPECT/CT offers a non-invasive method for differentiating renal lesions with low aggressiveness from other RCCs, in particular, clear cell renal cell carcinoma.
PURPOSE OF REVIEW: The majority of enhancing renal masses cannot be characterized through imaging as malignant or benign; however, such characterization could save patients from unnecessary surgery and/or biopsy and associated morbidity. Herein, we review the recent literature on the emerging use of 99mTc-MIBI SPECT/CT in preoperative differentiation of enhancing renal masses. RECENT FINDINGS: Recent reports have shown that 99mTc-MIBI SPECT/CT imaging can differentiate mitochondrial-rich, benign, or indolent renal masses from renal cell carcinoma. These studies demonstrate good correlation between a positive 99mTc-MIBI SPECT/CT scan and a pathologically proven diagnosis of renal oncocytoma and hybrid oncocytic/chromophobe tumor. In addition, there is excellent correlation between a negative scan and a diagnosis of clear cell subtype of renal cell carcinoma. Preoperative 99mTc-MIBI SPECT/CT offers a non-invasive method for differentiating renal lesions with low aggressiveness from other RCCs, in particular, clear cell renal cell carcinoma.
Authors: Steven C Campbell; Andrew C Novick; Arie Belldegrun; Michael L Blute; George K Chow; Ithaar H Derweesh; Martha M Faraday; Jihad H Kaouk; Raymond J Leveillee; Surena F Matin; Paul Russo; Robert G Uzzo Journal: J Urol Date: 2009-08-14 Impact factor: 7.450
Authors: Sara Sheikhbahaei; Christopher S Jones; Kristin K Porter; Steven P Rowe; Michael A Gorin; Alex S Baras; Phillip M Pierorazio; Mark W Ball; Takahiro Higuchi; Pamela T Johnson; Lilja B Solnes; Jonathan I Epstein; Mohamad E Allaf; Mehrbod S Javadi Journal: Clin Nucl Med Date: 2017-04 Impact factor: 7.794
Authors: Michael A Gorin; Steven P Rowe; Alexander S Baras; Lilja B Solnes; Mark W Ball; Phillip M Pierorazio; Christian P Pavlovich; Jonathan I Epstein; Mehrbod S Javadi; Mohamad E Allaf Journal: Eur Urol Date: 2015-09-18 Impact factor: 20.096
Authors: David C Johnson; Josip Vukina; Angela B Smith; Anne-Marie Meyer; Stephanie B Wheeler; Tzy-Mey Kuo; Hung-Jui Tan; Michael E Woods; Mathew C Raynor; Eric M Wallen; Raj S Pruthi; Matthew E Nielsen Journal: J Urol Date: 2014-07-27 Impact factor: 7.450
Authors: Steven P Rowe; Michael A Gorin; Jennifer Gordetsky; Mark W Ball; Phillip M Pierorazio; Takahiro Higuchi; Jonathan I Epstein; Mohamad E Allaf; Mehrbod S Javadi Journal: Clin Nucl Med Date: 2015-04 Impact factor: 7.794
Authors: Patrick O Richard; Philippe D Violette; Bimal Bhindi; Rodney H Breau; Wassim Kassouf; Luke T Lavallée; Michael Jewett; John R Kachura; Anil Kapoor; Maxine Noel-Lamy; Michael Ordon; Stephen E Pautler; Frédéric Pouliot; Alan I So; Ricardo A Rendon; Simon Tanguay; Christine Collins; Maryam Kandi; Bobby Shayegan; Andrew Weller; Antonio Finelli; Andrea Kokorovic; Jay Nayak Journal: Can Urol Assoc J Date: 2022-02 Impact factor: 1.862